Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

3,094.30INR
29 Apr 2016
Change (% chg)

-- (--)
Prev Close
Rs3,094.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
39,549
52-wk High
Rs4,382.95
52-wk Low
Rs2,750.00

REDY.BO

Chart for REDY.BO

About

Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Global Generics segment consists of its business of manufacturing and... (more)

Overall

Beta: 0.35
Market Cap(Mil.): Rs526,744.81
Shares Outstanding(Mil.): 170.54
Dividend: 20.00
Yield (%): 0.65

Financials

  REDY.BO Industry Sector
P/E (TTM): 150.17 34.16 45.44
EPS (TTM): 20.57 -- --
ROI: -- 13.08 12.53
ROE: -- 13.78 13.40
Search Stocks

BUZZ-India's Dr Reddy's rises on FDA approval for anti-nausea drug

** Dr Reddy's Laboratories rises as much as 3.5 pct, among top pct gainers on S&P BSE Healthcare index

03 Mar 2016

BUZZ-India's Dr. Reddy's rises for 2nd day as investors cheer buyback

** Dr. Reddy's Laboratories rises as much as 5.65 pct to 3,128 rupees, posts biggest intraday percentage gain in nearly 4 months

18 Feb 2016

MEDIA-Torrent Pharma, Dr. Reddy's, Aurobindo, Cipla, Lupin in race to buy Sagent Pharma - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy (Bengaluru newsroom)

25 Jan 2016

BUZZ-India's Dr. Reddy's rises on Nexium generic relaunch in U.S.

** Dr. Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, rises as much as 2.31 pct to its highest level since Dec 7

30 Dec 2015

BUZZ-India's Dr Reddy's slumps; US FDA releases details of warning letter

** US FDA releases details of warning letter (http://1.usa.gov/1QIDDeg)

26 Nov 2015

BUZZ-India's Dr Reddy's says adheres to all disclosure norms; stock recovers

** Dr Reddy's Laboratories' shares recover to trade 1 pct lower after falling as much as 6.8 pct intraday

19 Nov 2015

BUZZ-Indian drug makers attract short positions despite being oversold

** Indian drug makers attract short positions in derivatives even after being oversold

10 Nov 2015

BUZZ-Indian drug makers slump; US FDA scrutiny, weak earnings weigh

** Sun Pharmaceutical Industries slumps 5.3 pct, Dr.Reddy's Laboratories down 1.7 pct and Lupin falls 1.6 pct

09 Nov 2015

BUZZ-India's Dr.Reddy's slumps after US FDA warning letter

** Says API manufacturing facilities at including Srikakulam and Oncology formulation facility at Duvvada in Andhra Pradesh gets a warning letter from US FDA

06 Nov 2015

Earnings vs. Estimates

Search Stocks